Cargando…
Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study
The present study compares the structure and composition of fascia lata in healthy subjects and in patients with hip osteoarthritis (OA), to evaluate any differences in the amount of Collagen type I, Collagen type III, and Hyaluronan. Fascia lata samples from voluntary healthy subjects and patients...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625990/ https://www.ncbi.nlm.nih.gov/pubmed/34833012 http://dx.doi.org/10.3390/life11111136 |
_version_ | 1784606557031366656 |
---|---|
author | Fantoni, Ilaria Biz, Carlo Fan, Chenglei Pirri, Carmelo Fede, Caterina Petrelli, Lucia Ruggieri, Pietro De Caro, Raffaele Stecco, Carla |
author_facet | Fantoni, Ilaria Biz, Carlo Fan, Chenglei Pirri, Carmelo Fede, Caterina Petrelli, Lucia Ruggieri, Pietro De Caro, Raffaele Stecco, Carla |
author_sort | Fantoni, Ilaria |
collection | PubMed |
description | The present study compares the structure and composition of fascia lata in healthy subjects and in patients with hip osteoarthritis (OA), to evaluate any differences in the amount of Collagen type I, Collagen type III, and Hyaluronan. Fascia lata samples from voluntary healthy subjects and patients with OA were harvested during surgery. Collagen type I (COL I), III (COL III) antibody, and biotinylated hyaluronan binding protein (HABP) immunohistochemistry stainings were used to evaluate fascial morphology and COL I, COL III, and Hyaluronan (HA) content in both groups. Ten samples from healthy subjects and 11 samples from OA patients were collected. COL I was significantly more abundant in the OA group (p = 0.0015), with a median percentage positivity of 75.2 (IQR 13.11)%, while representing only 67 (IQR: 8.71)% in control cases. COL III, with median values of 9.5 (IQR 3.63)% (OA group) and 17.10 (IQR 11)% (control cases), respectively, showed significant reduction in OA patients (p = 0.002). HA showed a median value of 10.01 (IQR 8.11)% in OA patients, denoting significant decrease (p < 0.0001) with respect to the control group median 39.31 (IQR 5.62)%. The observed differences suggest a relationship between fascial pathology and hip OA. The observed increase in COL I in OA patients, along with the reduction of COL III and HA, could lead to fascial stiffening, which could alter fascial mechanics and be linked to the development and symptoms of OA. |
format | Online Article Text |
id | pubmed-8625990 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86259902021-11-27 Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study Fantoni, Ilaria Biz, Carlo Fan, Chenglei Pirri, Carmelo Fede, Caterina Petrelli, Lucia Ruggieri, Pietro De Caro, Raffaele Stecco, Carla Life (Basel) Article The present study compares the structure and composition of fascia lata in healthy subjects and in patients with hip osteoarthritis (OA), to evaluate any differences in the amount of Collagen type I, Collagen type III, and Hyaluronan. Fascia lata samples from voluntary healthy subjects and patients with OA were harvested during surgery. Collagen type I (COL I), III (COL III) antibody, and biotinylated hyaluronan binding protein (HABP) immunohistochemistry stainings were used to evaluate fascial morphology and COL I, COL III, and Hyaluronan (HA) content in both groups. Ten samples from healthy subjects and 11 samples from OA patients were collected. COL I was significantly more abundant in the OA group (p = 0.0015), with a median percentage positivity of 75.2 (IQR 13.11)%, while representing only 67 (IQR: 8.71)% in control cases. COL III, with median values of 9.5 (IQR 3.63)% (OA group) and 17.10 (IQR 11)% (control cases), respectively, showed significant reduction in OA patients (p = 0.002). HA showed a median value of 10.01 (IQR 8.11)% in OA patients, denoting significant decrease (p < 0.0001) with respect to the control group median 39.31 (IQR 5.62)%. The observed differences suggest a relationship between fascial pathology and hip OA. The observed increase in COL I in OA patients, along with the reduction of COL III and HA, could lead to fascial stiffening, which could alter fascial mechanics and be linked to the development and symptoms of OA. MDPI 2021-10-25 /pmc/articles/PMC8625990/ /pubmed/34833012 http://dx.doi.org/10.3390/life11111136 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fantoni, Ilaria Biz, Carlo Fan, Chenglei Pirri, Carmelo Fede, Caterina Petrelli, Lucia Ruggieri, Pietro De Caro, Raffaele Stecco, Carla Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study |
title | Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study |
title_full | Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study |
title_fullStr | Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study |
title_full_unstemmed | Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study |
title_short | Fascia Lata Alterations in Hip Osteoarthritis: An Observational Cross-Sectional Study |
title_sort | fascia lata alterations in hip osteoarthritis: an observational cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625990/ https://www.ncbi.nlm.nih.gov/pubmed/34833012 http://dx.doi.org/10.3390/life11111136 |
work_keys_str_mv | AT fantoniilaria fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy AT bizcarlo fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy AT fanchenglei fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy AT pirricarmelo fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy AT fedecaterina fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy AT petrellilucia fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy AT ruggieripietro fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy AT decaroraffaele fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy AT steccocarla fascialataalterationsinhiposteoarthritisanobservationalcrosssectionalstudy |